News and Events

View our monthly calendar for upcoming innovation information sessions, seminars, symposia and other events hosted by Enterprise Innovation and selected ecosystem partners.

Building Trust and Fostering Collaborations Key to Startup Formation

November 29, 2023

One of the hardest points on the translational road “from bench to bedside” can be the point where you have to turn over your discovery to a company you’ve founded—a company whose subsequent direction you won’t fully control.

New Radiopharmaceutical Shows Antitumor Activity in Patients with Advanced Prostate Cancer

November 3, 2023

Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial showed that the “radiopharmaceutical” was well tolerated and demonstrated promising antitumor activity, according to a new study published on Nov. 2 in the Journal of Clinical Oncology.

Dr. Chenxu Zhu Receives NIH Director’s New Innovator Award

October 2, 2023

Dr. Chenxu Zhu, an assistant professor of physiology and biophysics at Weill Cornell Medicine and a core faculty member of the New York Genome Center, has been awarded the National Institutes of Health Director’s New Innovator Award to fund an ambitious project to develop single-cell sequencing tools, known collectively as “multi-omics,” that will help track age-related changes in gene regulation programs, as well as cell decay, in brain cells from preclinical models.

Intercampus Symposium Brings Together Cornell Researchers Studying Metabolic Health

October 1, 2023

Diabetes, obesity, and metabolic diseases are complex health problems and important threats to human health. Ensuring optimal metabolic health requires multidisciplinary solutions. On Sept. 11 and 12, a cross-campus symposium brought together nearly 100 Cornell researchers from the Ithaca Campus and the Weill Cornell Medicine Campus in New York City to catalyze the kind of interdisciplinary collaborations necessary to address this growing health challenge. 

NIH Center Grant Bolsters Male Contraceptive Research

September 21, 2023

Weill Cornell Medicine has received a three-year, nearly $6 million grant to lead one of three national contraceptive research centers. The grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health, will fund the Weill Cornell Medicine Contraception Development Research Center. Led by Drs. Jochen Buck and Lonny Levin, both professors of pharmacology at Weill Cornell Medicine, the center will focus on developing an on-demand male contraceptive.

Budding Entrepreneurial Success at Weill Cornell Medicine-Qatar

September 18, 2023

Dr. Hani Najafi, an assistant professor of cell and developmental biology, was the first WCM-Q participant in the $100K Biomedical Business Plan Challenge Pitch Day competition hosted by the BioVenture eLab. Enterprise Innovation asked him to share his latest study that can lead to potential therapies for cardiometabolic diseases and obesity.

Entrepreneurship and the Power of Story Telling

September 12, 2023

An Accelerating BioVenture Innovation (ABI) student asked Dr. Erandi De Silva, the guest speaker of the Fall 2023 cohort kickoff event hosted on Aug. 29 in a packed Uris Auditorium, how she was able to convince venture capitalists with an idea of gene therapy development and operationalization on paper.

Potential Neuropathic Pain Treatment Shows Promise in Preclinical Tests

August 9, 2023

A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.

Stroke Detection and Education App Shows Encouraging Results in Pilot Program

July 24, 2023

In 2019, Dr. Evan Noch, an assistant professor of neurology at Weill Cornell Medicine, led a team of graduate students to win the “Most Impactful Hack” award at the third annual NYC Health Hackathon. After completing a pilot program at the Burke Neurological Institute, Destroke is set to refine its prototype, expand usership and conduct randomized trials with larger patient samples, including one at Weill Cornell Medicine.

High-Risk, High-Reward

July 5, 2023

Dr. Lisa Placanica (B.A. ’00, Ph.D. ’09), the senior managing director for CTL at Weill Cornell, and Dr. Juan Cubillos-Ruiz, the William J. Ledger, M.D., Distinguished Associate Professor for Infection and Immunology in Obstetrics and Gynecology, discuss how the ecosystem for innovation at Weill Cornell Medicine provides the support entrepreneurial faculty and students need to turn their promising research into commercially viable drugs and other treatments.
Read the latest news about Enterprise Innovation and Weill Cornell Medicine.

Weill Cornell Medicine Enterprise Innovation 1155 York Ave. New York, NY 10065 Phone: (646) 962-7045